CIK 0001723128 · Large accelerated filer
Amneal Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AMRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- Phone
- (908) 947-3120
- Former names
- Atlas Holdings, Inc.
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Open-market sale Executive Vice President sold 36,330 shares at $6.82 ($247,865)
- 4 Open-market sale Executive Vice President sold 36,330 shares at $6.87 ($249,489)
- 4 Option exercise Executive Vice President & CFO acquired 87,719 shares (option exercise)
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Executive Vice President gave up 14,878 shares (to pay taxes)
- 4 Shares withheld for taxes Executive Vice President gave up 15,155 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, General Counsel gave up 5,796 shares (to pay taxes)
- 4 Insider Changes in Ownership
- 10-K Report Annual Report
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Bylaws or fiscal year change
Page 21 of 35 · 695 filings